Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00017069
DRKS00017069
Recruiting
Not Applicable

on-interventional prospective research study by d-uo on intravesical instillation of mitomycin C in non-muscle invasive bladder cancer - THUROC

d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)0 sites500 target enrollmentApril 1, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC67Malignant neoplasm of bladder

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C67
Sponsor
d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)
Enrollment
500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
d-uo Deutsche Uro-Onkologen (Interessenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.)

Eligibility Criteria

Inclusion Criteria

  • •1\. age\> \= 18 years
  • •2\. gender: male or female
  • •3\. Written consent and consent to the processing of personal data given
  • •4\. Patients with histologically confirmed, non\-muscle\-invasive urothelial carcinoma of the bladder (typical bladder cancer)
  • •5\. Patients with planned or performed TUR\-B
  • •6\. Patients with planned instillation therapy with mitomycin C (Urocin®)

Exclusion Criteria

  • •1\. Presence of a bladder wall perforation
  • •2\. Other histological subtype as urothelial carcinoma (e.g., urinary bladder adenocarcinoma, squamous cell carcinoma of bladder)
  • •3\. cystitis
  • •4\. Hypersensitivity to mitomycin C or another component of Urocin® according to the SmPC
  • •5\. Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
on interventionel prospective study to develop a prognostic scoring system for outcome of autologous transplantation in multiple myeloma (MM).C90Multiple myeloma and malignant plasma cell neoplasms
DRKS00003964niversitätsklinikum Freiburg50
Not yet recruiting
Not Applicable
A study to assess the role of CognitiveBotics software (Artificial Intelligence based software) in the management of Autism Spectrum Disorder.Health Condition 1: F840- Autistic disorder
CTRI/2023/06/054257CognitiveBotics Technologies Private Limited
Active, not recruiting
Not Applicable
APPRECIATE
JPRN-jRCTs031210665Kawahito Yutaka55
Recruiting
Phase 2
Efficacy of Intraoperative Fluorescence Diagnosis in Meningioma surgerymeningiomaMeningioma
JPRN-jRCTs031210158Masahide Matsuda22
Recruiting
Not Applicable
on-interventional, prospective study to evaluate the predictive potential of early CRP kinetics, in particular the CRP flare-response phenomenon, on the efficacy of immunotherapy in advanced urooncological tumors (renal cell carcinoma, urothelial carcinoma). Prospective Evaluation of the CRP-FLAre phenomenon on Immunotherapy REsponse in Urooncology (FLAIRE).C64C65C66C67C68Malignant neoplasm of kidney, except renal pelvisMalignant neoplasm of renal pelvisMalignant neoplasm of ureterMalignant neoplasm of bladderMalignant neoplasm of other and unspecified urinary organs
DRKS00031957Klinik und Poliklinik fu¨r Urologie und Kinderurologie Universitätsklinikum Bonn200